Measles infections are not harmless – they can cause disease courses that may be of fatal outcome. Researchers of the Paul-Ehrlich-Institut (PEI) in co-operation with researchers from the UK and the
The vaccine rVSV-EBOV is currently used in the fight against Ebola virus. Since 2018, more than 200,000 people have been vaccinated. However, how the vaccine actually works was only partially known
An international team of researchers identifies the genetic basis for the hypervirulence of a Listeria strain that can cause severe infections. The work was coordinated by scientists at the Justus
Since the early ages green tea has been known for its numerous health benefits. A recent study goes further and shows that it also could help to fight antibiotic resistant bacteria. DZIF scientists at
Transplant patients are particularly susceptible to viral infections as they are given medication to suppress their immune system in order to prevent rejection. Several professional associations have
The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate
The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as
The natural antibiotic Lugdunin, discovered three years ago by Tübingen DZIF researchers, attacks pathogenic bacteria in several different ways simultaneously and also interacts with the defense
Researchers have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model. The team showed in its publication, that T-cell therapy can provide a
Looking for an effective treatment of serious influenza infections, researchers of the Paul-Ehrlich-Institut have used bioinformatics to screen licensed medicines for their potential efficacy against
